SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-19-000419
Filing Date
2019-01-23
Accepted
2019-01-23 17:18:21
Documents
3
Period of Report
2019-01-18
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ohr-8k_011819.htm 8-K 49742
2 CERTIFICATE OF AMENDMENT TO THE CERTIFICATE OF INCORPORATION ex3-1.htm EX-3.1 11357
3 PRESS RELEASE ex99-1.htm EX-99.1 22070
  Complete submission text file 0001387131-19-000419.txt   84692
Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 19538100
SIC: 2834 Pharmaceutical Preparations